Skip to main content

Jean-Jacques Bienaimé

Equibles does not estimate personal net worth.

Get an email with a short summary when Immunome Inc. publishes a filing, an earnings call transcript or a press release.

Get IMNM alerts

About Jean-Jacques Bienaimé

Jean-Jacques Bienaimé is recorded as Board Member at Immunome Inc. (IMNM) since November 7, 2023. Immunome Inc. reported in an 8-K filed November 8, 2023 that Jean-Jacques Bienaimé was appointed Class II director, effective November 7, 2023. Immunome Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Immunome Inc. includes Clay B. Siegall, Ph.D. (CEO), Clay Siegall (CEO), Corleen Roche (CFO) and 7 others.

“On November 7, 2023, the Board of Directors (the "Board") of Immunome, Inc. (the "Company"), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Jean-Jacques Bienaimé as a Class II director of the Company, with a term of office expiring at the 2025 annual meeting of stockholders.”
Immunome Inc. Form 8-K, filed November 8, 2023 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Board Member

2023-11-07–present

Leadership on record at Immunome Inc.

Recent activity